Login / Signup

Vasculitis beyond the areas of Botulinum toxin-A injection, increasing concerns?

Nastaran NamaziNiloufar Najar Nobari
Published in: Journal of cosmetic dermatology (2020)
Using the unapproved Botulinum toxin-A should be discouraged due to their hazard of systemic reactions and clinicians should avoid administering the unlicensed products even by patients request or lack of the allergic reactions from previous injections.
Keyphrases
  • botulinum toxin
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • ultrasound guided
  • prognostic factors
  • palliative care
  • patient reported outcomes
  • atopic dermatitis